Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS LUPIN DR. DATSONS LABS/
LUPIN
 
P/E (TTM) x -10.9 -303.0 - View Chart
P/BV x 0.2 3.9 4.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   LUPIN
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
LUPIN
Mar-20
DR. DATSONS LABS/
LUPIN
5-Yr Chart
Click to enlarge
High Rs126882 14.2%   
Low Rs31505 6.1%   
Sales per share (Unadj.) Rs133.0339.4 39.2%  
Earnings per share (Unadj.) Rs0.2-5.9 -2.5%  
Cash flow per share (Unadj.) Rs6.615.5 42.7%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8276.7 46.5%  
Shares outstanding (eoy) m31.66453.00 7.0%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.62.0 28.8%   
Avg P/E ratio x516.1-116.6 -442.5%  
P/CF ratio (eoy) x11.844.8 26.4%  
Price / Book Value ratio x0.62.5 24.2%  
Dividend payout %0-100.9 0.0%   
Avg Mkt Cap Rs m2,477314,201 0.8%   
No. of employees `000NA18.3 0.0%   
Total wages/salary Rs m5629,868 0.2%   
Avg. sales/employee Rs ThNM8,400.6-  
Avg. wages/employee Rs ThNM1,632.0-  
Avg. net profit/employee Rs ThNM-147.2-  
INCOME DATA
Net Sales Rs m4,211153,748 2.7%  
Other income Rs m794,838 1.6%   
Total revenues Rs m4,289158,585 2.7%   
Gross profit Rs m56924,849 2.3%  
Depreciation Rs m2049,702 2.1%   
Interest Rs m4303,630 11.9%   
Profit before tax Rs m1316,355 0.1%   
Minority Interest Rs m04 0.0%   
Prior Period Items Rs m-239 -4.6%   
Extraordinary Inc (Exp) Rs m0-7,521 0.0%   
Tax Rs m611,571 0.1%   
Profit after tax Rs m5-2,694 -0.2%  
Gross profit margin %13.516.2 83.6%  
Effective tax rate %48.070.8 67.9%   
Net profit margin %0.1-1.8 -6.5%  
BALANCE SHEET DATA
Current assets Rs m6,852154,132 4.4%   
Current liabilities Rs m6,71192,252 7.3%   
Net working cap to sales %3.340.2 8.3%  
Current ratio x1.01.7 61.1%  
Inventory Days Days16182 196.0%  
Debtors Days Days318129 246.3%  
Net fixed assets Rs m3,67389,082 4.1%   
Share capital Rs m317906 34.9%   
"Free" reserves Rs m3,761124,461 3.0%   
Net worth Rs m4,078125,367 3.3%   
Long term debt Rs m1,67117,933 9.3%   
Total assets Rs m12,633249,839 5.1%  
Interest coverage x1.05.5 18.7%   
Debt to equity ratio x0.40.1 286.5%  
Sales to assets ratio x0.30.6 54.2%   
Return on assets %3.40.4 919.2%  
Return on equity %0.1-2.1 -5.5%  
Return on capital %7.78.7 87.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96451,450 1.9%   
Fx outflow Rs m60719,470 3.1%   
Net fx Rs m35731,980 1.1%   
CASH FLOW
From Operations Rs m1,34514,688 9.2%  
From Investments Rs m-2,25611,070 -20.4%  
From Financial Activity Rs m-1,200-8,906 13.5%  
Net Cashflow Rs m-2,11116,853 -12.5%  

Share Holding

Indian Promoters % 4.5 46.6 9.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 31.9 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.1 931.7%  
Shareholders   20,807 98,259 21.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS